Weigao was founded in 1988 and started its business with a tax turnover of 25,000 yuan. At present, the company is committed to developing its main business, medical devices and medicine, and at the same time developing industries such as construction and finance. Weigao Holdings Company is a Weigao Group, Weigao Construction Industry Group and Weigao Financial Holdings Group, covering an area of ​​more than 6 million square meters, with more than 80 subsidiaries and 2 listed companies, with more than 30,000 employees. Weigao Group is under 12 industrial groups: medical products, blood purification, orthopedics, pharmaceuticals, interventional, medical business, Shengji, Purui, Jierui, blood technology, medical engineering, and medical robots; the main businesses of the Construction Industry Group are Real estate, building materials, hotels, food, and tourism; the main businesses of the Financial Holding Group include asset and fund management, credit, equity investment, and securities management. It has infusion consumables and equipment, blood transfusion equipment, intracardiac consumables, indwelling needles and various abnormal needles, blood purification equipment and consumables, orthopedic materials, surgical equipment and accessories, trauma care, surgical robots, minimally invasive equipment and equipment, ICU products More than 1,000 varieties and more than 150,000 specifications, including accessories, large-capacity injections and other drugs, nephrological products, biological diagnostic reagents, surgical sutures, dental implants, sensor control equipment and consumables, PVC and non-PVC raw materials, etc. Medical devices have entered 11 fields in the 15 major market segments around the world, becoming a global manufacturer of comprehensive, safe, reliable and trustworthy overall medical system solutions. Winning the National 863 Industrialization Base, National Torch Plan Key High-tech Enterprise, National Intellectual Property Demonstration Enterprise, Industry Leading Enterprise, National Contract-abiding and Credit-Respecting Enterprise, National Independent Innovation Demonstration Unit, National May 1st Labor Certificate, China Industrial Award, and National Implementation Excellent performance advanced model enterprise, Shandong Governor Quality Award, China Quality Award nomination award, Global Excellence Performance Award and other honorary titles. Weihai Blue Ocean Bank is approved by the China Banking Regulatory Commission.

Shandong Weigao Interventional Medical Technology Co., Ltd. was established in Weihai High-tech Development Zone. It is a secondary industrial group under Weigao Group Co., Ltd. with nearly 400 employees. It is a company that mainly produces and operates interventional equipment and consumables. Industrial Group.

The Industrial Group consists of Shandong Weixin, Weigao Medical Devices, Weihai Gaowei, Shenzhen Jinrui Kaili, Shandong Hua'an, Shandong Zurich and other companies. The main production directions of the Industrial Group's products include coronary interventional treatment, congenital heart disease, and cerebrovascular diseases. , gastrointestinal tract and other non-vascular diseases, peripheral vascular diseases and cardiac electrophysiological diseases interventional equipment consumables, etc.; business and sales products include: cardiac stents, balloons, guidewires; congenital occlusion devices; filters; non-vascular stents; electrolytic detachment Spring coils, micro guidewires; central venous catheters, disposable pressure sets and other products.